Advertisement
Screener

Alkermes plc. (ALKS) Investment Income, Interest

2.8 / 5 stars · 68/120 Roast Me

Alkermes plc. Investment Income, Interest

Alkermes plc. (ALKS) reported Investment Income, Interest of $5.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.

Financial Statements › Income Statement › Other Income

us-gaap:InvestmentIncomeInterest · last filed 2026-07-28

  • Alkermes plc. investment income, interest for the quarter ending 2026-06-30 was $5.34M, a 51.81% decline year-over-year.
  • Alkermes plc. investment income, interest for the quarter ending 2026-03-31 was $8.54M, a 15.80% decline year-over-year.
  • Alkermes plc. investment income, interest for the quarter ending 2025-12-31 was $12.13M, a 6.40% increase year-over-year.
  • Alkermes plc. investment income, interest for the quarter ending 2025-09-30 was $11.94M, a 9.41% increase year-over-year.
  • Alkermes plc. investment income, interest for fiscal 2025 was $45.30M, a 6.72% increase from fiscal 2024.
  • Alkermes plc. investment income, interest for fiscal 2024 was $42.45M, a 37.58% increase from fiscal 2023.
  • Alkermes plc. investment income, interest for fiscal 2023 was $30.85M, a 304.43% increase from fiscal 2022.
  • Alkermes plc. investment income, interest for fiscal 2022 was $7.63M, a 216.82% increase from fiscal 2021.
Period endInvestment Income, Interest 3 monthInvestment Income, Interest 6 monthInvestment Income, Interest 9 monthInvestment Income, Interest 12 month
2026-06-30$5.34M
10-Q · filed 2026-07-28
$13.88M
10-Q · filed 2026-07-28
$26.01M
derived: sum of 3 quarters · filed 2026-07-28
$37.96M
derived: sum of 4 quarters · filed 2026-07-28
2026-03-31$8.54M
10-Q · filed 2026-05-05
$20.67M
derived: sum of 2 quarters · filed 2026-05-05
$32.61M
derived: sum of 3 quarters · filed 2026-05-05
$43.70M
derived: sum of 4 quarters · filed 2026-07-28
2025-12-31$12.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$24.07M
derived: sum of 2 quarters · filed 2026-02-25
$35.16M
derived: sum of 3 quarters · filed 2026-07-28
$45.30M
10-K · filed 2026-02-25
2025-09-30$11.94M
10-Q · filed 2025-10-28
$23.03M
derived: sum of 2 quarters · filed 2026-07-28
$33.17M
10-Q · filed 2025-10-28
$44.57M
derived: sum of 4 quarters · filed 2026-07-28
2025-06-30$11.09M
10-Q · filed 2026-07-28
$21.23M
10-Q · filed 2026-07-28
$32.63M
derived: sum of 3 quarters · filed 2026-07-28
$43.55M
derived: sum of 4 quarters · filed 2026-07-28
2025-03-31$10.14M
10-Q · filed 2026-05-05
$21.54M
derived: sum of 2 quarters · filed 2026-05-05
$32.46M
derived: sum of 3 quarters · filed 2026-05-05
$43.19M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$11.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$22.32M
derived: sum of 2 quarters · filed 2026-02-25
$33.05M
derived: sum of 3 quarters · filed 2026-02-25
$42.45M
10-K · filed 2026-02-25
2024-09-30$10.92M
10-Q · filed 2025-10-28
$21.65M
derived: sum of 2 quarters · filed 2025-10-28
$31.05M
10-Q · filed 2025-10-28
$40.80M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$10.73M
10-Q · filed 2025-07-29
$20.13M
10-Q · filed 2025-07-29
$29.88M
derived: sum of 3 quarters · filed 2026-02-25
$39.25M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$9.40M
10-Q · filed 2025-05-01
$19.15M
derived: sum of 2 quarters · filed 2026-02-25
$28.52M
derived: sum of 3 quarters · filed 2026-02-25
$35.29M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$9.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$19.12M
derived: sum of 2 quarters · filed 2026-02-25
$25.89M
derived: sum of 3 quarters · filed 2026-02-25
$30.85M
10-K · filed 2026-02-25
2023-09-30$9.37M
10-Q · filed 2024-10-24
$16.14M
derived: sum of 2 quarters · filed 2024-10-24
$21.11M
10-Q · filed 2024-10-24
$25.03M
derived: sum of 4 quarters · filed 2025-02-12
2023-06-30$6.77M
10-Q · filed 2024-07-24
$11.73M
10-Q · filed 2024-07-24
$15.66M
derived: sum of 3 quarters · filed 2025-02-12
$17.89M
derived: sum of 4 quarters · filed 2025-02-12
2023-03-31$4.97M
10-Q · filed 2024-05-01
$8.89M
derived: sum of 2 quarters · filed 2025-02-12
$11.13M
derived: sum of 3 quarters · filed 2025-02-12
$12.02M
derived: sum of 4 quarters · filed 2025-02-12
2022-12-31$3.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12
$6.16M
derived: sum of 2 quarters · filed 2025-02-12
$7.06M
derived: sum of 3 quarters · filed 2025-02-12
$7.63M
10-K · filed 2025-02-12
2022-09-30$2.24M
10-Q · filed 2023-10-25
$3.13M
derived: sum of 2 quarters · filed 2023-10-25
$3.71M
10-Q · filed 2023-10-25
$4.16M
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30$896.00K
10-Q · filed 2023-07-26
$1.47M
10-Q · filed 2023-07-26
$1.92M
derived: sum of 3 quarters · filed 2024-02-21
$2.39M
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31$573.00K
10-Q · filed 2023-04-26
$1.03M
derived: sum of 2 quarters · filed 2024-02-21
$1.49M
derived: sum of 3 quarters · filed 2024-02-21
$2.12M
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31$453.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
$921.00K
derived: sum of 2 quarters · filed 2024-02-21
$1.54M
derived: sum of 3 quarters · filed 2024-02-21
$2.41M
10-K · filed 2024-02-21
2021-09-30$468.00K
10-Q · filed 2022-11-02
$1.09M
derived: sum of 2 quarters · filed 2022-11-02
$1.96M
10-Q · filed 2022-11-02
$2.99M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30$623.00K
10-Q · filed 2022-07-27
$1.49M
10-Q · filed 2022-07-27
$2.52M
derived: sum of 3 quarters · filed 2023-02-16
$3.90M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31$864.00K
10-Q · filed 2022-04-27
$1.90M
derived: sum of 2 quarters · filed 2023-02-16
$3.28M
derived: sum of 3 quarters · filed 2023-02-16
$5.06M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$2.41M
derived: sum of 2 quarters · filed 2023-02-16
$4.20M
derived: sum of 3 quarters · filed 2023-02-16
$6.96M
10-K · filed 2023-02-16
2020-09-30$1.38M
10-Q · filed 2021-10-27
$3.16M
derived: sum of 2 quarters · filed 2021-10-27
$5.92M
10-Q · filed 2021-10-27
$9.12M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30$1.79M
10-Q · filed 2021-07-28
$4.55M
10-Q · filed 2021-07-28
$7.74M
derived: sum of 3 quarters · filed 2022-02-16
$11.25M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31$2.76M
10-Q · filed 2021-04-28
$5.95M
derived: sum of 2 quarters · filed 2022-02-16
$9.46M
derived: sum of 3 quarters · filed 2022-02-16
$13.17M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31$3.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$6.70M
derived: sum of 2 quarters · filed 2022-02-16
$10.41M
derived: sum of 3 quarters · filed 2022-02-16
$13.98M
10-K · filed 2022-02-16
2019-09-30$3.51M
10-Q · filed 2020-10-29
$7.21M
derived: sum of 2 quarters · filed 2020-10-29
$10.79M
10-Q · filed 2020-10-29
$14.08M
derived: sum of 4 quarters · filed 2021-02-11
2019-06-30$3.71M
10-Q · filed 2020-07-29
$7.28M
10-Q · filed 2020-07-29
$10.57M
derived: sum of 3 quarters · filed 2021-02-11
$13.13M
derived: sum of 4 quarters · filed 2021-02-11
2019-03-31$3.57M
10-Q · filed 2020-04-29
$6.86M
derived: sum of 2 quarters · filed 2021-02-11
$9.42M
derived: sum of 3 quarters · filed 2021-02-11
$11.32M
derived: sum of 4 quarters · filed 2021-02-11
2018-12-31$3.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11
$5.85M
derived: sum of 2 quarters · filed 2021-02-11
$7.75M
derived: sum of 3 quarters · filed 2021-02-11
$9.24M
10-K · filed 2021-02-11
2018-09-30$2.56M
10-Q · filed 2019-10-23
$4.46M
derived: sum of 2 quarters · filed 2019-10-23
$5.95M
10-Q · filed 2019-10-23
$7.31M
derived: sum of 4 quarters · filed 2020-02-13
2018-06-30$1.90M
10-Q · filed 2019-07-25
$3.39M
10-Q · filed 2019-07-25
$4.75M
derived: sum of 3 quarters · filed 2020-02-13
$5.92M
derived: sum of 4 quarters · filed 2020-02-13
2018-03-31$1.49M
10-Q · filed 2019-04-25
$2.85M
derived: sum of 2 quarters · filed 2020-02-13
$4.02M
derived: sum of 3 quarters · filed 2020-02-13
$5.19M
derived: sum of 4 quarters · filed 2020-02-13
2017-12-31$1.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13
$2.54M
derived: sum of 2 quarters · filed 2020-02-13
$3.71M
derived: sum of 3 quarters · filed 2020-02-13
$4.65M
10-K · filed 2020-02-13
2017-09-30$1.17M
10-Q · filed 2018-10-23
$2.34M
derived: sum of 2 quarters · filed 2018-10-23
$3.29M
10-Q · filed 2018-10-23
$4.12M
derived: sum of 4 quarters · filed 2019-02-15
2017-06-30$1.17M
10-Q · filed 2018-07-26
$2.11M
10-Q · filed 2018-07-26
$2.95M
derived: sum of 3 quarters · filed 2019-02-15
$3.86M
derived: sum of 4 quarters · filed 2019-02-15
2017-03-31$943.00K
10-Q · filed 2018-04-26
$1.78M
derived: sum of 2 quarters · filed 2019-02-15
$2.69M
derived: sum of 3 quarters · filed 2019-02-15
$3.68M
derived: sum of 4 quarters · filed 2019-02-15
2016-12-31$835.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15
$1.75M
derived: sum of 2 quarters · filed 2019-02-15
$2.74M
derived: sum of 3 quarters · filed 2019-02-15
$3.75M
10-K · filed 2019-02-15
2016-09-30$912.00K
10-Q · filed 2017-10-26
$1.91M
derived: sum of 2 quarters · filed 2017-10-26
$2.92M
10-Q · filed 2017-10-26
$3.93M
derived: sum of 4 quarters · filed 2018-02-16
2016-06-30$994.00K
10-Q · filed 2017-07-27
$2.00M
10-Q · filed 2017-07-27
$3.02M
derived: sum of 3 quarters · filed 2018-02-16
$3.88M
derived: sum of 4 quarters · filed 2018-02-16
2016-03-31$1.01M
10-Q · filed 2017-04-27
$2.02M
derived: sum of 2 quarters · filed 2018-02-16
$2.89M
derived: sum of 3 quarters · filed 2018-02-16
$3.68M
derived: sum of 4 quarters · filed 2018-02-16
2015-12-31$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
$1.88M
derived: sum of 2 quarters · filed 2018-02-16
$2.67M
derived: sum of 3 quarters · filed 2018-02-16
$3.33M
10-K · filed 2018-02-16
2015-09-30$865.00K
10-Q · filed 2016-11-02
$1.66M
derived: sum of 2 quarters · filed 2016-11-02
$2.32M
10-Q · filed 2016-11-02
$2.91M
derived: sum of 4 quarters · filed 2017-02-17
2015-06-30$795.00K
10-Q · filed 2016-07-28
$1.46M
10-Q · filed 2016-07-28
$2.05M
derived: sum of 3 quarters · filed 2017-02-17
$2.59M
derived: sum of 4 quarters · filed 2017-02-17
2015-03-31$660.00K
10-Q · filed 2016-04-28
$1.25M
derived: sum of 2 quarters · filed 2017-02-17
$1.80M
derived: sum of 3 quarters · filed 2017-02-17
$2.12M
derived: sum of 4 quarters · filed 2017-02-17
2014-12-31$592.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17
$1.14M
derived: sum of 2 quarters · filed 2017-02-17
$1.46M
derived: sum of 3 quarters · filed 2017-02-17
$1.97M
10-K · filed 2017-02-17
2014-09-30$546.00K
10-Q · filed 2015-10-29
$869.00K
derived: sum of 2 quarters · filed 2015-10-29
$1.38M
10-Q · filed 2015-10-29
$1.64M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$323.00K
10-Q · filed 2015-07-30
$834.00K
10-Q · filed 2015-07-30
$1.09M
derived: sum of 3 quarters · filed 2016-02-25
$1.38M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$511.00K
10-Q · filed 2015-04-30
$766.00K
derived: sum of 2 quarters · filed 2016-02-25
$1.06M
derived: sum of 3 quarters · filed 2016-02-25
$1.22M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$255.00K
derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25
$550.00K
derived: sum of 2 quarters · filed 2016-02-25
$711.00K
10-K · filed 2016-02-25
$882.00K
derived: sum of 4 quarters · filed 2016-02-25
2013-09-30$295.00K
10-Q · filed 2014-10-29
$456.00K
10-Q · filed 2013-10-31
$627.00K
10-Q · filed 2014-10-29
$782.00K
derived: sum of 4 quarters · filed 2014-10-29
2013-06-30$161.00K
10-Q · filed 2014-07-31
$332.00K
10-Q · filed 2014-07-31
$487.00K
derived: sum of 3 quarters · filed 2014-07-31
$703.00K
derived: sum of 4 quarters · filed 2014-07-31
2013-03-31$171.00K
10-Q · filed 2014-04-30
$326.00K
derived: sum of 2 quarters · filed 2014-04-30
$542.00K
derived: sum of 3 quarters · filed 2014-04-30
$841.00K
10-K · filed 2015-02-24
2012-12-31$155.00K
10-Q · filed 2013-01-31
$371.00K
derived: sum of 2 quarters · filed 2013-10-31
$670.00K
10-Q · filed 2013-01-31
$951.00K
derived: sum of 4 quarters · filed 2014-02-27
2012-09-30$216.00K
10-Q · filed 2013-10-31
$515.00K
10-Q · filed 2013-10-31
$796.00K
derived: sum of 3 quarters · filed 2014-02-27
$1.15M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30$299.00K
10-Q · filed 2013-07-25
$580.00K
derived: sum of 2 quarters · filed 2014-02-27
$930.00K
derived: sum of 3 quarters · filed 2014-02-27
$1.31M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31$281.00K
derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27
$631.00K
derived: sum of 2 quarters · filed 2014-02-27
$1.01M
derived: sum of 3 quarters · filed 2014-02-27
$1.52M
10-KT · filed 2014-02-27
2011-12-31$350.00K
10-Q · filed 2013-01-31
$733.00K
derived: sum of 2 quarters · filed 2013-01-31
$1.24M
10-Q · filed 2013-01-31
$1.79M
derived: sum of 4 quarters · filed 2013-05-23
2011-09-30$383.00K
10-Q · filed 2012-11-01
$885.00K
10-Q · filed 2012-11-01
$1.44M
derived: sum of 3 quarters · filed 2013-05-23
$2.09M
derived: sum of 4 quarters · filed 2013-05-23
2011-06-30$502.00K
10-Q · filed 2012-07-26
$1.05M
derived: sum of 2 quarters · filed 2013-05-23
$1.71M
derived: sum of 3 quarters · filed 2013-05-23
$2.38M
derived: sum of 4 quarters · filed 2013-05-23
2011-03-31$553.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-23
$1.20M
derived: sum of 2 quarters · filed 2013-05-23
$1.88M
derived: sum of 3 quarters · filed 2013-05-23
$2.73M
10-K · filed 2013-05-23
2010-12-31$650.00K
10-Q · filed 2012-02-02
$1.32M
derived: sum of 2 quarters · filed 2012-02-02
$2.17M
10-Q · filed 2012-02-02
2010-09-30$673.00K
10-Q · filed 2011-11-03
$1.52M
10-Q · filed 2011-11-03
2010-03-31$4.67M
10-K · filed 2012-05-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76